What should you know about AEC immunohistochemistry?

AEC creates a red-coloured reaction where the targeted marker is detected. It is part of the laboratory staining method, not a diagnosis or a treatment.

The laboratory applies an antibody chosen to recognise a particular protein in the biopsy tissue. AEC then helps reveal where that antibody has attached by producing visible red staining. The pathologist examines the location, pattern and strength of the reaction alongside the cells' appearance and other test results.

A positive stain means the target was detected in the tested tissue under the laboratory's interpretation criteria. It does not, by itself, identify a cancer type or determine treatment. A negative result may mean the target was not detected, but sample quality, tissue handling and technical controls also matter.

Read the AEC finding within the final pathology diagnosis rather than as a stand-alone answer. Check which protein the antibody targeted, which cells showed staining and whether the report describes the pattern as supportive, inconclusive or not supportive of a diagnosis.

If wording is unclear, request an explanation of how the stain fits with the tissue appearance and the rest of the marker panel. Occasionally, the team may need another stain, review of the existing sample or additional tissue before reaching a firm conclusion.

AEC staining itself happens in the laboratory and causes no symptoms in the person whose tissue was tested. Contact the clinical team if you have not received a plan for discussing the biopsy result, or if the report and the explanation you received appear inconsistent.

Seek prompt medical help for worsening symptoms related to the biopsy site, such as increasing redness, swelling, drainage, fever or bleeding that does not settle with the instructions you were given. These concerns relate to the biopsy procedure, not to the AEC reagent.

Ask which protein was tested, what cells stained, how the result affects the final diagnosis, and whether other markers agreed. You can also ask whether the sample was adequate and what unresolved uncertainty remains.